Boston Scientific Key Executives
This section highlights Boston Scientific's key executives, including their titles and compensation details.
Find Contacts at Boston Scientific
(Showing 0 of )
Boston Scientific Earnings
This section highlights Boston Scientific's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
Time:
Est. EPS:
$-
Status:
Unconfirmed
Last Earnings Results
Date:
September 29, 2023
EPS:
$0.34
Est. EPS:
$-
Revenue:
$3.53B
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-05 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-10-23 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-07-24 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-04-24 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-01-31 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-10-26 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-27 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-04-26 | N/A | N/A |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Healthcare
Medical - Devices
$122.18
Stock Price
$175.45B
Market Cap
53.00K
Employees
Marlborough, MA
Location
Financial Statements
Access annual & quarterly financial statements for Boston Scientific, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B |
| Cost of Revenue | $5.26B | $4.34B | $4.00B | $3.76B | $3.51B |
| Gross Profit | $11.49B | $9.89B | $8.68B | $8.13B | $6.40B |
| Gross Profit Ratio | 68.61% | 69.50% | 68.44% | 68.40% | 64.59% |
| Research and Development Expenses | $1.61B | $1.41B | $1.32B | $1.20B | $1.14B |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $5.98B | $5.19B | $4.52B | $4.36B | $3.79B |
| Other Expenses | $1.29B | $948.00M | $803.00M | $741.00M | $789.00M |
| Operating Expenses | $8.89B | $7.55B | $6.65B | $6.30B | $5.72B |
| Cost and Expenses | $14.14B | $11.90B | $10.65B | $10.06B | $9.23B |
| Interest Income | $107.00M | $22.00M | $10.00M | $4.00M | $3.00M |
| Interest Expense | $305.00M | $265.00M | $470.00M | $341.00M | $361.00M |
| Depreciation and Amortization | $- | $1.20B | $1.14B | $1.09B | $1.12B |
| EBITDA | $2.60B | $3.45B | $2.74B | $2.52B | $1.51B |
| EBITDA Ratio | 15.54% | 24.25% | 22.08% | 23.42% | 18.49% |
| Operating Income | $2.60B | $2.34B | $1.65B | $2.04B | $1.04B |
| Operating Income Ratio | 15.54% | 16.45% | 13.00% | 17.19% | 10.53% |
| Total Other Income Expenses Net | $-321.00M | $-358.00M | $-508.00M | $-123.00M | $-1.12B |
| Income Before Tax | $2.28B | $1.99B | $1.14B | $1.08B | $-138.00M |
| Income Before Tax Ratio | 13.63% | 13.94% | 9.00% | 9.05% | -1.39% |
| Income Tax Expense | $436.00M | $393.00M | $443.00M | $36.00M | $2.00M |
| Net Income | $1.85B | $1.59B | $698.00M | $1.04B | $-140.00M |
| Net Income Ratio | 11.06% | 11.19% | 5.50% | 8.76% | -1.41% |
| EPS | $1.26 | $1.08 | $0.45 | $0.69 | $-0.10 |
| EPS Diluted | $1.25 | $1.07 | $0.45 | $0.69 | $-0.10 |
| Weighted Average Shares Outstanding | 1.47B | 1.45B | 1.43B | 1.42B | 1.42B |
| Weighted Average Shares Outstanding Diluted | 1.49B | 1.46B | 1.44B | 1.43B | 1.42B |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.56B | $4.21B | $4.12B | $3.86B | $3.73B | $3.53B | $3.60B | $3.39B | $3.24B | $3.17B | $3.24B | $3.03B | $3.13B | $2.93B | $3.08B | $2.75B | $2.71B | $2.66B | $2.00B | $2.54B |
| Cost of Revenue | $1.47B | $1.31B | $1.53B | $1.21B | $1.15B | $1.11B | $1.07B | $1.04B | $1.02B | $990.00M | $1.02B | $967.00M | $982.00M | $914.00M | $957.00M | $906.00M | $1.01B | $881.00M | $799.00M | $818.00M |
| Gross Profit | $3.10B | $2.90B | $2.58B | $2.65B | $2.58B | $2.42B | $2.53B | $2.35B | $2.22B | $2.18B | $2.22B | $2.06B | $2.15B | $2.02B | $2.12B | $1.85B | $1.69B | $1.78B | $1.20B | $1.73B |
| Gross Profit Ratio | 67.86% | 68.80% | 62.70% | 68.60% | 69.20% | 68.50% | 70.30% | 69.30% | 68.40% | 68.80% | 68.50% | 68.00% | 68.60% | 68.80% | 68.90% | 67.10% | 62.56% | 66.87% | 60.11% | 67.83% |
| Research and Development Expenses | $459.00M | $407.00M | $383.00M | $366.00M | $363.00M | $356.00M | $359.00M | $337.00M | $330.00M | $339.00M | $335.00M | $319.00M | $320.00M | $310.00M | $298.00M | $276.00M | $286.00M | $315.00M | $242.00M | $300.00M |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.03B | $984.00M | $798.00M | $978.00M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $1.61B | $1.56B | $1.45B | $1.36B | $1.38B | $1.24B | $1.35B | $1.22B | $1.16B | $1.13B | $1.17B | $1.06B | $1.15B | $1.07B | $1.12B | $1.02B | $1.03B | $984.00M | $798.00M | $978.00M |
| Other Expenses | $349.00M | $195.00M | $-9.00M | $-224.00M | $64.00M | $-18.00M | $-18.00M | $214.00M | $199.00M | $202.00M | $204.00M | $198.00M | $26.00M | $181.00M | $-26.00M | $37.00M | $352.00M | $64.00M | $-18.00M | $-36.00M |
| Operating Expenses | $2.42B | $2.16B | $1.84B | $1.95B | $1.96B | $1.81B | $1.92B | $1.77B | $1.69B | $1.67B | $1.70B | $1.58B | $1.67B | $1.56B | $1.60B | $1.48B | $1.51B | $1.50B | $1.24B | $1.48B |
| Cost and Expenses | $3.89B | $3.48B | $3.37B | $3.16B | $3.11B | $2.92B | $2.99B | $2.81B | $2.72B | $2.66B | $2.73B | $2.54B | $2.65B | $2.47B | $2.56B | $2.39B | $2.52B | $2.38B | $2.04B | $2.30B |
| Interest Income | $107.00M | $- | $- | $- | $22.00M | $66.00M | $70.00M | $65.00M | $4.00M | $1.00M | $1.00M | $4.00M | $1.00M | $1.00M | $1.00M | $1.00M | $- | $1.00M | $- | $1.00M |
| Interest Expense | $80.00M | $79.00M | $77.00M | $69.00M | $65.00M | $66.00M | $70.00M | $65.00M | $64.00M | $63.00M | $64.00M | $279.00M | $87.00M | $86.00M | $86.00M | $82.00M | $96.00M | $86.00M | $91.00M | $88.00M |
| Depreciation and Amortization | $348.00M | $306.00M | $311.00M | $304.00M | $313.00M | $301.00M | $298.00M | $285.00M | $294.00M | $284.00M | $284.00M | $274.00M | $290.00M | $272.00M | $263.00M | $268.00M | $194.00M | $282.00M | $275.00M | $277.00M |
| EBITDA | $1.01B | $1.05B | $812.00M | $984.00M | $883.00M | $976.00M | $795.00M | $796.00M | $757.00M | $593.00M | $692.00M | $725.00M | $498.00M | $841.00M | $500.00M | $682.00M | $597.00M | $145.00M | $191.00M | $392.00M |
| EBITDA Ratio | 22.21% | 25.04% | 25.68% | 25.96% | 27.28% | 22.71% | 22.17% | 21.95% | 24.21% | 20.79% | 21.86% | 21.45% | 22.35% | 28.10% | 21.90% | 21.40% | 27.07% | 20.46% | 7.19% | 16.16% |
| Operating Income | $675.00M | $733.00M | $747.00M | $693.00M | $584.00M | $693.00M | $514.00M | $552.00M | $586.00M | $358.00M | $423.00M | $466.00M | $180.00M | $387.00M | $262.00M | $370.00M | $-8.00M | $-205.00M | $-71.00M | $146.00M |
| Operating Income Ratio | 14.80% | 17.42% | 18.13% | 17.97% | 15.68% | 19.65% | 14.28% | 16.29% | 18.08% | 11.29% | 13.04% | 15.40% | 5.76% | 13.20% | 8.51% | 13.44% | -0.30% | -7.71% | -3.54% | 5.74% |
| Total Other Income Expenses Net | $-90.00M | $-64.00M | $-100.00M | $-67.00M | $-79.00M | $-83.00M | $-88.00M | $-108.00M | $-53.00M | $-113.00M | $-78.00M | $-310.00M | $-61.00M | $96.00M | $-113.00M | $-45.00M | $-386.00M | $-22.00M | $-110.00M | $-124.00M |
| Income Before Tax | $585.00M | $669.00M | $420.00M | $608.00M | $505.00M | $610.00M | $426.00M | $444.00M | $396.00M | $245.00M | $345.00M | $156.00M | $120.00M | $483.00M | $149.00M | $325.00M | $248.00M | $-227.00M | $-181.00M | $22.00M |
| Income Before Tax Ratio | 12.83% | 15.89% | 10.19% | 15.77% | 13.56% | 17.30% | 11.84% | 13.10% | 12.21% | 7.73% | 10.64% | 5.16% | 3.84% | 16.47% | 4.84% | 11.81% | 9.16% | -8.54% | -9.04% | 0.87% |
| Income Tax Expense | $23.00M | $200.00M | $98.00M | $115.00M | $1.00M | $105.00M | $156.00M | $131.00M | $256.00M | $57.00M | $85.00M | $45.00M | $26.00M | $64.00M | $-37.00M | $-16.00M | $96.00M | $-72.00M | $-33.00M | $12.00M |
| Net Income | $566.00M | $468.00M | $324.00M | $492.00M | $505.00M | $504.00M | $270.00M | $314.00M | $140.00M | $174.00M | $246.00M | $96.00M | $82.00M | $405.00M | $172.00M | $327.00M | $152.00M | $-155.00M | $-147.00M | $11.00M |
| Net Income Ratio | 12.41% | 11.12% | 7.86% | 12.76% | 13.56% | 14.29% | 7.50% | 9.27% | 4.32% | 5.49% | 7.58% | 3.17% | 2.62% | 13.81% | 5.59% | 11.88% | 5.61% | -5.83% | -7.34% | 0.43% |
| EPS | $0.38 | $0.32 | $0.22 | $0.34 | $0.34 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | $0.17 | $0.07 | $0.07 | $0.29 | $0.13 | $0.24 | $0.11 | $-0.11 | $-0.11 | $0.01 |
| EPS Diluted | $0.38 | $0.32 | $0.22 | $0.33 | $0.34 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | $0.17 | $0.07 | $0.07 | $0.29 | $0.13 | $0.24 | $0.11 | $-0.11 | $-0.10 | $0.01 |
| Weighted Average Shares Outstanding | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.46B | 1.45B | 1.44B | 1.43B | 1.43B | 1.43B | 1.43B | 1.43B | 1.42B | 1.42B | 1.42B | 1.43B | 1.41B | 1.38B | 1.40B |
| Weighted Average Shares Outstanding Diluted | 1.49B | 1.49B | 1.48B | 1.48B | 1.48B | 1.48B | 1.46B | 1.45B | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B | 1.43B | 1.43B | 1.44B | 1.43B | 1.41B | 1.41B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $414.00M | $865.00M | $928.00M | $1.93B | $1.73B |
| Short Term Investments | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $414.00M | $865.00M | $928.00M | $1.93B | $1.73B |
| Net Receivables | $2.56B | $2.23B | $1.97B | $1.78B | $1.53B |
| Inventory | $2.81B | $2.48B | $1.87B | $1.61B | $1.35B |
| Other Current Assets | $1.14B | $937.00M | $995.00M | $1.00B | $2.08B |
| Total Current Assets | $6.92B | $6.51B | $5.76B | $6.32B | $6.69B |
| Property Plant Equipment Net | $3.29B | $3.30B | $2.83B | $2.69B | $2.54B |
| Goodwill | $17.09B | $14.39B | $12.92B | $11.99B | $9.95B |
| Intangible Assets | $6.68B | $6.00B | $5.90B | $6.12B | $5.92B |
| Goodwill and Intangible Assets | $23.77B | $20.39B | $18.82B | $18.11B | $15.87B |
| Long Term Investments | $- | $413.00M | $407.00M | $412.00M | $918.00M |
| Tax Assets | $3.65B | $3.84B | $3.94B | $4.14B | $4.21B |
| Other Non-Current Assets | $1.75B | $680.00M | $707.00M | $563.00M | $545.00M |
| Total Non-Current Assets | $32.48B | $28.62B | $26.71B | $25.91B | $24.08B |
| Other Assets | $- | $- | $- | $2.00M | $3.00M |
| Total Assets | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B |
| Account Payables | $960.00M | $942.00M | $862.00M | $794.00M | $513.00M |
| Short Term Debt | $1.78B | $531.00M | $20.00M | $261.00M | $13.00M |
| Tax Payables | $307.00M | $220.00M | $232.00M | $209.00M | $158.00M |
| Deferred Revenue | $- | $266.00M | $220.00M | $208.00M | $138.00M |
| Other Current Liabilities | $3.35B | $2.97B | $2.47B | $2.80B | $2.86B |
| Total Current Liabilities | $6.40B | $4.93B | $3.80B | $4.27B | $3.68B |
| Long Term Debt | $8.97B | $8.96B | $9.26B | $9.19B | $9.53B |
| Deferred Revenue Non-Current | $- | $311.00M | $289.00M | $276.00M | $257.00M |
| Deferred Tax Liabilities Non-Current | $155.00M | $134.00M | $144.00M | $310.00M | $330.00M |
| Other Non-Current Liabilities | $1.87B | $1.27B | $1.40B | $1.55B | $1.66B |
| Total Non-Current Liabilities | $10.99B | $10.67B | $11.09B | $11.33B | $11.77B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $17.39B | $15.61B | $14.90B | $15.61B | $15.45B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M |
| Retained Earnings | $2.67B | $819.00M | $-750.00M | $-1.39B | $-2.38B |
| Accumulated Other Comprehensive Income Loss | $275.00M | $49.00M | $269.00M | $263.00M | $207.00M |
| Other Total Stockholders Equity | $18.80B | $18.40B | $18.04B | $17.73B | $17.48B |
| Total Stockholders Equity | $21.77B | $19.28B | $17.57B | $16.62B | $15.33B |
| Total Equity | $22.00B | $19.53B | $17.57B | $16.62B | $15.33B |
| Total Liabilities and Stockholders Equity | $39.40B | $34.89B | $32.47B | $32.23B | $30.78B |
| Minority Interest | $233.00M | $248.00M | $- | $- | $- |
| Total Liabilities and Total Equity | $39.40B | $34.89B | $32.47B | $32.23B | $30.78B |
| Total Investments | $555.00M | $413.00M | $407.00M | $412.00M | $918.00M |
| Total Debt | $10.75B | $9.49B | $9.28B | $9.45B | $9.54B |
| Net Debt | $10.33B | $8.63B | $8.35B | $7.53B | $7.80B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $414.00M | $2.50B | $2.99B | $2.33B | $865.00M | $952.00M | $426.00M | $570.00M | $928.00M | $338.00M | $276.00M | $325.00M | $1.93B | $1.95B | $2.67B | $2.02B | $1.73B | $2.02B | $1.72B | $370.00M |
| Short Term Investments | $- | $- | $- | $1.73B | $- | $- | $- | $- | $- | $- | $- | $7.00M | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $414.00M | $2.50B | $2.99B | $2.33B | $865.00M | $952.00M | $426.00M | $570.00M | $928.00M | $338.00M | $276.00M | $325.00M | $1.93B | $1.95B | $2.67B | $2.02B | $1.73B | $2.02B | $1.72B | $370.00M |
| Net Receivables | $2.56B | $2.50B | $2.40B | $2.30B | $2.23B | $2.10B | $2.13B | $2.08B | $1.97B | $1.87B | $1.92B | $1.87B | $1.78B | $1.67B | $1.68B | $1.63B | $1.53B | $1.60B | $1.46B | $1.70B |
| Inventory | $2.81B | $2.75B | $2.61B | $2.56B | $2.48B | $2.40B | $2.25B | $2.05B | $1.87B | $1.79B | $1.75B | $1.74B | $1.61B | $1.60B | $1.43B | $1.41B | $1.35B | $1.47B | $1.52B | $1.63B |
| Other Current Assets | $1.14B | $1.00B | $1.07B | $991.00M | $937.00M | $1.05B | $1.08B | $1.01B | $995.00M | $1.15B | $1.14B | $1.14B | $1.00B | $1.01B | $978.00M | $1.05B | $2.08B | $1.07B | $1.11B | $1.12B |
| Total Current Assets | $6.92B | $8.76B | $8.99B | $8.19B | $6.51B | $6.50B | $5.89B | $5.70B | $5.76B | $5.14B | $5.08B | $5.07B | $6.32B | $6.23B | $6.76B | $6.10B | $6.69B | $6.16B | $5.80B | $4.82B |
| Property Plant Equipment Net | $3.74B | $3.50B | $3.37B | $3.33B | $3.30B | $3.08B | $2.98B | $2.88B | $2.83B | $2.66B | $2.65B | $2.69B | $2.69B | $2.52B | $2.49B | $2.46B | $2.54B | $2.38B | $2.39B | $2.42B |
| Goodwill | $17.09B | $15.03B | $14.40B | $14.36B | $14.39B | $13.61B | $13.66B | $13.27B | $12.92B | $12.85B | $12.88B | $12.95B | $11.99B | $11.82B | $10.87B | $10.87B | $9.95B | $10.14B | $10.10B | $10.10B |
| Intangible Assets | $6.68B | $5.75B | $5.42B | $5.84B | $6.00B | $5.85B | $6.06B | $6.06B | $5.90B | $6.06B | $6.35B | $6.58B | $6.12B | $6.23B | $5.79B | $5.99B | $5.92B | $6.80B | $7.16B | $7.39B |
| Goodwill and Intangible Assets | $23.77B | $20.79B | $19.81B | $20.20B | $20.39B | $19.46B | $19.72B | $19.33B | $18.82B | $18.91B | $19.23B | $19.53B | $18.11B | $18.05B | $16.66B | $16.86B | $15.87B | $16.93B | $17.26B | $17.49B |
| Long Term Investments | $555.00M | $532.00M | $589.00M | $429.00M | $413.00M | $427.00M | $421.00M | $385.00M | $407.00M | $381.00M | $376.00M | $399.00M | $412.00M | $434.00M | $616.00M | $643.00M | $918.00M | $567.00M | $467.00M | $437.00M |
| Tax Assets | $3.65B | $3.82B | $3.80B | $3.79B | $3.84B | $3.84B | $3.87B | $3.90B | $3.94B | $4.02B | $4.06B | $4.10B | $4.14B | $4.05B | $4.04B | $4.17B | $4.21B | $4.17B | $4.18B | $4.16B |
| Other Non-Current Assets | $749.00M | $684.00M | $546.00M | $737.00M | $679.00M | $732.00M | $728.00M | $697.00M | $707.00M | $834.00M | $791.00M | $552.00M | $563.00M | $594.00M | $603.00M | $664.00M | $545.00M | $636.00M | $717.00M | $775.00M |
| Total Non-Current Assets | $32.48B | $29.32B | $28.12B | $28.48B | $28.62B | $27.54B | $27.72B | $27.19B | $26.71B | $26.80B | $27.10B | $27.27B | $25.91B | $25.65B | $24.41B | $24.80B | $24.08B | $24.68B | $25.02B | $25.29B |
| Other Assets | $-1.00M | $- | $- | $1.00M | $1.00M | $- | $-1.00M | $-2.00M | $- | $-1.00M | $3.00M | $-2.00M | $2.00M | $- | $1.00M | $- | $3.00M | $1.00M | $-2.00M | $-1.00M |
| Total Assets | $39.40B | $38.08B | $37.11B | $36.67B | $35.14B | $34.04B | $33.60B | $32.89B | $32.47B | $31.95B | $32.19B | $32.34B | $32.23B | $31.88B | $31.17B | $30.90B | $30.78B | $30.84B | $30.82B | $30.11B |
| Account Payables | $960.00M | $907.00M | $906.00M | $921.00M | $942.00M | $929.00M | $899.00M | $868.00M | $862.00M | $803.00M | $732.00M | $696.00M | $794.00M | $674.00M | $689.00M | $615.00M | $513.00M | $452.00M | $408.00M | $605.00M |
| Short Term Debt | $1.78B | $1.65B | $1.58B | $1.08B | $531.00M | $513.00M | $559.00M | $510.00M | $20.00M | $20.00M | $170.00M | $238.00M | $261.00M | $261.00M | $262.00M | $13.00M | $13.00M | $11.00M | $254.00M | $1.00B |
| Tax Payables | $268.00M | $332.00M | $224.00M | $257.00M | $220.00M | $352.00M | $400.00M | $281.00M | $232.00M | $234.00M | $257.00M | $459.00M | $209.00M | $113.00M | $121.00M | $151.00M | $158.00M | $37.00M | $193.00M | $246.00M |
| Deferred Revenue | $306.00M | $290.00M | $284.00M | $280.00M | $266.00M | $246.00M | $242.00M | $231.00M | $220.00M | $216.00M | $222.00M | $212.00M | $208.00M | $160.00M | $141.00M | $139.00M | $138.00M | $147.00M | $143.00M | $141.00M |
| Other Current Liabilities | $3.09B | $2.73B | $2.58B | $2.37B | $2.97B | $2.54B | $2.46B | $2.19B | $2.47B | $2.28B | $2.50B | $2.67B | $2.80B | $2.81B | $2.86B | $2.48B | $2.86B | $2.65B | $2.11B | $1.98B |
| Total Current Liabilities | $6.40B | $5.91B | $5.58B | $4.92B | $4.93B | $4.58B | $4.56B | $4.08B | $3.80B | $3.55B | $3.88B | $4.28B | $4.27B | $4.02B | $4.07B | $3.39B | $3.68B | $3.30B | $3.11B | $3.98B |
| Long Term Debt | $9.37B | $9.61B | $9.36B | $9.92B | $8.96B | $8.79B | $8.89B | $8.86B | $9.26B | $8.91B | $9.16B | $9.45B | $9.19B | $9.20B | $9.20B | $9.44B | $9.53B | $9.33B | $9.54B | $9.59B |
| Deferred Revenue Non-Current | $329.00M | $328.00M | $316.00M | $314.00M | $311.00M | $301.00M | $295.00M | $290.00M | $289.00M | $278.00M | $279.00M | $279.00M | $276.00M | $296.00M | $283.00M | $264.00M | $257.00M | $6.00M | $251.00M | $251.00M |
| Deferred Tax Liabilities Non-Current | $155.00M | $138.00M | $132.00M | $132.00M | $134.00M | $91.00M | $135.00M | $210.00M | $144.00M | $278.00M | $265.00M | $261.00M | $310.00M | $274.00M | $115.00M | $336.00M | $330.00M | $522.00M | $585.00M | $589.00M |
| Other Non-Current Liabilities | $1.14B | $1.14B | $1.12B | $1.22B | $1.27B | $1.16B | $1.23B | $1.34B | $1.40B | $1.29B | $1.35B | $1.34B | $1.55B | $1.62B | $1.55B | $1.75B | $1.66B | $2.13B | $1.73B | $1.90B |
| Total Non-Current Liabilities | $10.99B | $11.21B | $10.92B | $11.59B | $10.67B | $10.34B | $10.55B | $10.70B | $11.09B | $10.76B | $11.05B | $11.33B | $11.33B | $11.39B | $11.15B | $11.79B | $11.77B | $11.98B | $12.10B | $12.33B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $17.39B | $17.12B | $16.50B | $16.50B | $15.61B | $14.91B | $15.12B | $14.78B | $14.90B | $14.31B | $14.94B | $15.60B | $15.61B | $15.41B | $15.23B | $15.18B | $15.45B | $15.28B | $15.21B | $16.31B |
| Preferred Stock | $- | $- | $- | $18.21B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $16.00M |
| Retained Earnings | $2.67B | $2.11B | $1.64B | $1.31B | $819.00M | $315.00M | $-189.00M | $-450.00M | $-750.00M | $-876.00M | $-1.05B | $-1.30B | $-1.39B | $-1.47B | $-1.88B | $-2.05B | $-2.38B | $-2.57B | $-2.40B | $-2.25B |
| Accumulated Other Comprehensive Income Loss | $275.00M | $-128.00M | $164.00M | $132.00M | $49.00M | $231.00M | $208.00M | $178.00M | $269.00M | $532.00M | $433.00M | $222.00M | $263.00M | $238.00M | $237.00M | $254.00M | $207.00M | $151.00M | $131.00M | $168.00M |
| Other Total Stockholders Equity | $18.80B | $18.71B | $18.55B | $18.46B | $18.40B | $18.32B | $18.19B | $18.11B | $18.31B | $17.97B | $17.85B | $17.79B | $17.73B | $17.68B | $17.57B | $17.50B | $17.48B | $17.97B | $17.87B | $15.87B |
| Total Stockholders Equity | $21.77B | $20.71B | $20.37B | $19.93B | $19.28B | $18.89B | $18.23B | $17.85B | $17.57B | $17.64B | $17.25B | $16.73B | $16.62B | $16.46B | $15.94B | $15.72B | $15.33B | $15.56B | $15.62B | $13.80B |
| Total Equity | $22.00B | $20.96B | $20.61B | $20.17B | $19.53B | $19.13B | $18.48B | $18.11B | $17.57B | $17.64B | $17.25B | $16.73B | $16.62B | $16.46B | $15.94B | $15.72B | $15.33B | $15.56B | $15.62B | $13.80B |
| Total Liabilities and Stockholders Equity | $39.40B | $38.08B | $37.11B | $36.43B | $34.89B | $33.80B | $33.60B | $32.89B | $32.47B | $31.95B | $32.19B | $32.34B | $32.23B | $31.88B | $31.17B | $30.90B | $30.78B | $30.84B | $30.82B | $30.11B |
| Minority Interest | $233.00M | $248.00M | $238.00M | $242.00M | $248.00M | $243.00M | $259.00M | $259.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $39.40B | $38.08B | $37.11B | $36.43B | $34.89B | $33.80B | $33.60B | $32.89B | $32.47B | $31.95B | $32.19B | $32.34B | $32.23B | $31.88B | $31.17B | $30.90B | $30.78B | $30.84B | $30.82B | $30.11B |
| Total Investments | $555.00M | $532.00M | $589.00M | $1.73B | $413.00M | $427.00M | $421.00M | $385.00M | $407.00M | $381.00M | $376.00M | $406.00M | $412.00M | $434.00M | $616.00M | $643.00M | $918.00M | $567.00M | $467.00M | $437.00M |
| Total Debt | $11.15B | $11.26B | $10.94B | $11.00B | $9.49B | $9.30B | $9.45B | $9.37B | $9.28B | $8.93B | $9.33B | $9.68B | $9.45B | $9.46B | $9.46B | $9.44B | $9.54B | $9.33B | $9.79B | $10.60B |
| Net Debt | $10.73B | $8.76B | $7.95B | $8.67B | $8.63B | $8.35B | $9.03B | $8.79B | $8.35B | $8.60B | $9.05B | $9.36B | $7.53B | $7.51B | $6.79B | $7.43B | $7.80B | $7.31B | $8.06B | $10.23B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $1.85B | $1.59B | $698.00M | $1.04B | $-82.00M |
| Depreciation and Amortization | $1.27B | $1.20B | $1.14B | $1.09B | $1.12B |
| Deferred Income Tax | $- | $-1.00M | $-63.00M | $-124.00M | $-82.00M |
| Stock Based Compensation | $266.00M | $233.00M | $220.00M | $194.00M | $170.00M |
| Change in Working Capital | $- | $-770.00M | $-1.00B | $-351.00M | $42.00M |
| Accounts Receivables | $-351.00M | $-238.00M | $-220.00M | $-279.00M | $335.00M |
| Inventory | $-228.00M | $-660.00M | $-321.00M | $-346.00M | $-65.00M |
| Accounts Payables | $243.00M | $118.00M | $-255.00M | $408.00M | $88.00M |
| Other Working Capital | $- | $10.00M | $-209.00M | $-134.00M | $-316.00M |
| Other Non Cash Items | $54.00M | $253.00M | $540.00M | $17.00M | $337.00M |
| Net Cash Provided by Operating Activities | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B |
| Investments in Property Plant and Equipment | $-790.00M | $-711.00M | $-612.00M | $-554.00M | $-376.00M |
| Acquisitions Net | $-4.64B | $-1.81B | $-1.54B | $-1.43B | $12.00M |
| Purchases of Investments | $- | $- | $-24.00M | $96.00M | $-146.00M |
| Sales Maturities of Investments | $- | $- | $56.00M | $294.00M | $12.00M |
| Other Investing Activities | $-257.00M | $-52.00M | $106.00M | $-1.00M | $87.00M |
| Net Cash Used for Investing Activities | $-5.69B | $-2.57B | $-2.01B | $-1.60B | $-411.00M |
| Debt Repayment | $1.83B | $-4.00M | $-165.00M | $- | $-999.00M |
| Common Stock Issued | $- | $182.00M | $- | $110.00M | $975.00M |
| Common Stock Repurchased | $- | $182.00M | $136.00M | $110.00M | $-535.00M |
| Dividends Paid | $- | $-28.00M | $-55.00M | $-55.00M | $-28.00M |
| Other Financing Activities | $-13.00M | $37.00M | $-464.00M | $-40.00M | $880.00M |
| Net Cash Used Provided by Financing Activities | $1.81B | $5.00M | $-548.00M | $-95.00M | $293.00M |
| Effect of Forex Changes on Cash | $-11.00M | $-4.00M | $-9.00M | $-6.00M | $-2.00M |
| Net Change in Cash | $-449.00M | $-71.00M | $-1.04B | $173.00M | $1.39B |
| Cash at End of Period | $606.00M | $1.05B | $1.13B | $2.17B | $2.00B |
| Cash at Beginning of Period | $1.05B | $1.13B | $2.17B | $2.00B | $607.00M |
| Operating Cash Flow | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B |
| Capital Expenditure | $-790.00M | $-800.00M | $-612.00M | $-554.00M | $-376.00M |
| Free Cash Flow | $2.65B | $1.70B | $914.00M | $1.32B | $1.13B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $562.00M | $700.00M | $324.00M | $493.00M | $504.00M | $504.00M | $270.00M | $314.00M | $140.00M | $188.00M | $260.00M | $110.00M | $95.00M | $419.00M | $186.00M | $341.00M | $210.00M | $-155.00M | $-148.00M | $11.00M |
| Depreciation and Amortization | $348.00M | $636.00M | $311.00M | $304.00M | $313.00M | $300.00M | $298.00M | $285.00M | $294.00M | $284.00M | $284.00M | $274.00M | $290.00M | $272.00M | $263.00M | $268.00M | $289.00M | $282.00M | $275.00M | $277.00M |
| Deferred Income Tax | $-80.00M | $-11.00M | $-10.00M | $31.00M | $73.00M | $-29.00M | $-64.00M | $19.00M | $7.00M | $23.00M | $-18.00M | $-75.00M | $-75.00M | $39.00M | $-87.00M | $-1.00M | $- | $-28.00M | $8.00M | $7.00M |
| Stock Based Compensation | $69.00M | $-61.00M | $195.00M | $63.00M | $59.00M | $59.00M | $60.00M | $55.00M | $55.00M | $58.00M | $55.00M | $52.00M | $49.00M | $51.00M | $47.00M | $47.00M | $42.00M | $40.00M | $46.00M | $42.00M |
| Change in Working Capital | $324.00M | $523.00M | $-209.00M | $-743.00M | $-57.00M | $-176.00M | $-14.00M | $-523.00M | $334.00M | $-304.00M | $-353.00M | $-682.00M | $-35.00M | $-211.00M | $248.00M | $-353.00M | $-117.00M | $320.00M | $18.00M | $-580.00M |
| Accounts Receivables | $-90.00M | $-175.00M | $-114.00M | $-114.00M | $-74.00M | $-3.00M | $-75.00M | $-86.00M | $-44.00M | $-14.00M | $-96.00M | $-66.00M | $-148.00M | $14.00M | $-28.00M | $-117.00M | $93.00M | $-123.00M | $204.00M | $161.00M |
| Inventory | $46.00M | $-89.00M | $-95.00M | $-124.00M | $-59.00M | $-202.00M | $-214.00M | $-185.00M | $-46.00M | $-95.00M | $-72.00M | $-108.00M | $-31.00M | $-215.00M | $15.00M | $-115.00M | $-64.00M | $35.00M | $163.00M | $-199.00M |
| Accounts Payables | $385.00M | $69.00M | $71.00M | $-450.00M | $23.00M | $17.00M | $289.00M | $-211.00M | $335.00M | $-141.00M | $-81.00M | $-368.00M | $133.00M | $-65.00M | $333.00M | $7.00M | $88.00M | $- | $- | $- |
| Other Working Capital | $-17.00M | $718.00M | $-71.00M | $-55.00M | $53.00M | $12.00M | $-14.00M | $482.00M | $89.00M | $-54.00M | $-104.00M | $-140.00M | $144.00M | $55.00M | $-72.00M | $-128.00M | $-146.00M | $408.00M | $-349.00M | $-542.00M |
| Other Non Cash Items | $233.00M | $-785.00M | $1.16B | $14.00M | $65.00M | $40.00M | $108.00M | $40.00M | $-23.00M | $221.00M | $79.00M | $263.00M | $154.00M | $-105.00M | $-14.00M | $-18.00M | $249.00M | $184.00M | $70.00M | $166.00M |
| Net Cash Provided by Operating Activities | $1.46B | $1.00B | $813.00M | $164.00M | $957.00M | $698.00M | $658.00M | $190.00M | $807.00M | $470.00M | $307.00M | $-58.00M | $478.00M | $465.00M | $643.00M | $284.00M | $673.00M | $643.00M | $269.00M | $-77.00M |
| Investments in Property Plant and Equipment | $-277.00M | $-179.00M | $-155.00M | $-245.00M | $-267.00M | $-206.00M | $-206.00M | $-121.00M | $-200.00M | $-172.00M | $-105.00M | $-131.00M | $-266.00M | $-107.00M | $-106.00M | $-75.00M | $-159.00M | $-150.00M | $-95.00M | $-102.00M |
| Acquisitions Net | $-3.42B | $-1.13B | $-48.00M | $-47.00M | $-793.00M | $1.00M | $-643.00M | $-375.00M | $-5.00M | $-71.00M | $1.00M | $-1.47B | $-219.00M | $-1.31B | $3.00M | $95.00M | $-15.00M | $- | $12.00M | $- |
| Purchases of Investments | $- | $- | $-73.00M | $-66.00M | $-28.00M | $-16.00M | $-63.00M | $-10.00M | $15.00M | $-22.00M | $1.00M | $-15.00M | $51.00M | $-21.00M | $-17.00M | $-13.00M | $-16.00M | $-101.00M | $-27.00M | $-2.00M |
| Sales Maturities of Investments | $- | $- | $- | $- | $28.00M | $15.00M | $2.00M | $10.00M | $70.00M | $22.00M | $-2.00M | $32.00M | $-50.00M | $207.00M | $-10.00M | $25.00M | $- | $- | $1.00M | $- |
| Other Investing Activities | $-9.00M | $-121.00M | $4.00M | $-1.00M | $7.00M | $9.00M | $70.00M | $12.00M | $-63.00M | $18.00M | $76.00M | $11.00M | $74.00M | $22.00M | $133.00M | $39.00M | $28.00M | $122.00M | $50.00M | $28.00M |
| Net Cash Used for Investing Activities | $-3.70B | $-1.43B | $-271.00M | $-285.00M | $-1.05B | $-197.00M | $-840.00M | $-484.00M | $-183.00M | $-225.00M | $-29.00M | $-1.57B | $-461.00M | $-1.21B | $-133.00M | $71.00M | $-147.00M | $-129.00M | $-59.00M | $-76.00M |
| Debt Repayment | $189.00M | $22.00M | $- | $1.62B | $- | $-41.00M | $37.00M | $- | $- | $-155.00M | $-11.00M | $60.00M | $- | $- | $- | $- | $-260.00M | $-250.00M | $-835.00M | $346.00M |
| Common Stock Issued | $- | $96.00M | $26.00M | $80.00M | $17.00M | $75.00M | $27.00M | $63.00M | $19.00M | $59.00M | $6.00M | $- | $8.00M | $64.00M | $20.00M | $- | $- | $- | $933.00M | $42.00M |
| Common Stock Repurchased | $- | $- | $- | $80.00M | $119.00M | $- | $- | $63.00M | $136.00M | $- | $- | $52.00M | $110.00M | $- | $- | $18.00M | $-535.00M | $- | $- | $- |
| Dividends Paid | $- | $-23.00M | $- | $- | $- | $- | $-14.00M | $-14.00M | $-13.00M | $-14.00M | $-14.00M | $-14.00M | $-13.00M | $-14.00M | $-14.00M | $-14.00M | $-14.00M | $-14.00M | $- | $- |
| Other Financing Activities | $25.00M | $1.58B | $24.00M | $-47.00M | $15.00M | $57.00M | $20.00M | $-55.00M | $14.00M | $-89.00M | $-325.00M | $-104.00M | $5.00M | $20.00M | $16.00M | $-81.00M | $-10.00M | $-44.00M | $1.01B | $-132.00M |
| Net Cash Used Provided by Financing Activities | $214.00M | $1.68B | $24.00M | $1.57B | $15.00M | $16.00M | $43.00M | $-69.00M | $1.00M | $-199.00M | $-344.00M | $-6.00M | $-8.00M | $6.00M | $2.00M | $-95.00M | $-819.00M | $-249.00M | $1.10B | $256.00M |
| Effect of Forex Changes on Cash | $-9.00M | $-2.00M | $-1.00M | $-7.00M | $4.00M | $-5.00M | $-3.00M | $- | $3.00M | $-6.00M | $-6.00M | $-1.00M | $-1.00M | $-3.00M | $1.00M | $-3.00M | $6.00M | $1.00M | $1.00M | $-9.00M |
| Net Change in Cash | $-2.04B | $-413.00M | $566.00M | $1.44B | $-77.00M | $512.00M | $-143.00M | $-363.00M | $629.00M | $39.00M | $-71.00M | $-1.64B | $9.00M | $-739.00M | $645.00M | $258.00M | $-287.00M | $266.00M | $1.32B | $93.00M |
| Cash at End of Period | $606.00M | $2.65B | $2.99B | $2.50B | $1.05B | $1.13B | $620.00M | $763.00M | $1.13B | $497.00M | $458.00M | $529.00M | $2.17B | $2.16B | $2.90B | $2.25B | $2.00B | $2.28B | $2.02B | $700.00M |
| Cash at Beginning of Period | $2.65B | $3.06B | $2.42B | $1.05B | $1.13B | $620.00M | $763.00M | $1.13B | $497.00M | $458.00M | $529.00M | $2.17B | $2.16B | $2.90B | $2.25B | $2.00B | $2.28B | $2.02B | $700.00M | $607.00M |
| Operating Cash Flow | $1.46B | $1.00B | $813.00M | $164.00M | $957.00M | $698.00M | $658.00M | $190.00M | $807.00M | $470.00M | $307.00M | $-58.00M | $478.00M | $465.00M | $643.00M | $284.00M | $673.00M | $643.00M | $269.00M | $-77.00M |
| Capital Expenditure | $-293.00M | $-304.00M | $-155.00M | $-245.00M | $-267.00M | $-206.00M | $-206.00M | $-121.00M | $-200.00M | $-172.00M | $-105.00M | $-131.00M | $-266.00M | $-107.00M | $-106.00M | $-75.00M | $-159.00M | $-150.00M | $-95.00M | $-102.00M |
| Free Cash Flow | $1.16B | $698.00M | $658.00M | $-81.00M | $690.00M | $492.00M | $452.00M | $69.00M | $607.00M | $298.00M | $202.00M | $-189.00M | $212.00M | $358.00M | $537.00M | $209.00M | $514.00M | $493.00M | $174.00M | $-179.00M |
Boston Scientific Dividends
Explore Boston Scientific's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
4.35x
Boston Scientific Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $1.375 | $1.375 | May 12, 2023 | June 01, 2023 | ||
| $1.375 | $1.375 | August 12, 2021 | |||
| $1.375 | $1.375 | May 13, 2021 | |||
| $1.375 | $1.375 | February 11, 2021 | |||
| $1.375 | $1.375 | November 12, 2020 | |||
| $1.4361 | $1.4361 | August 13, 2020 |
Boston Scientific News
Read the latest news about Boston Scientific, including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for BSX-PA.